Viewing Study NCT05436418

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2026-02-03 @ 7:00 AM
Study NCT ID: NCT05436418
Status: RECRUITING
Last Update Posted: 2025-12-16
First Post: 2022-06-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral Blood Stem Cell Transplantation View
None Hematopoietic Stem Cell Transplantation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Reduced Intensity Conditioning View
None Systemic Immunosuppressive Therapy View
None Hematologic Malignancy View
None Acute Myeloid Leukemia View
None Calcineurin Inhibitor View